{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:57:51Z","timestamp":1789844271766,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Outer membrane vesicles (OMV) derived from <jats:italic>Bordetella pertussis\u2014<\/jats:italic>the etiologic agent of the resurgent disease called pertussis\u2014are safe and effective in preventing bacterial colonization in the lungs of immunized mice. Vaccine formulations containing those OMV are capable of inducing a mixed Th1\/Th2\/Th17 profile, but even more interestingly, they may induce a tissue-resident memory immune response. This immune response is recommended for the new generation of pertussis-vaccines that must be developed to overcome the weaknesses of current commercial acellular vaccines (second-generation of pertussis vaccine). The third-generation of pertussis vaccine should also deal with infections caused by bacteria that currently circulate in the population and are phenotypically and genotypically different [in particular those deficient in the expression of pertactin antigen, PRN(-)] from those that circulated in the past. Here we evaluated the protective capacity of OMV derived from bacteria grown in biofilm, since it was observed that, by difference with older culture collection vaccine strains, circulating clinical <jats:italic>B. pertussis<\/jats:italic> isolates possess higher capacity for this lifestyle. Therefore, we performed studies with a clinical isolate with good biofilm-forming capacity. Biofilm lifestyle was confirmed by both scanning electron microscopy and proteomics. While scanning electron microscopy revealed typical biofilm structures in these cultures, BipA, fimbria, and other adhesins described as typical of the biofilm lifestyle were overexpressed in the biofilm culture in comparison with planktonic culture. OMV derived from biofilm (OMVbiof) or planktonic lifestyle (OMVplank) were used to formulate vaccines to compare their immunogenicity and protective capacities against infection with PRN(+) or PRN(-) <jats:italic>B. pertussis<\/jats:italic> clinical isolates. Using the mouse protection model, we detected that OMVbiof-vaccine was more immunogenic than OMVplank-vaccine in terms of both specific antibody titers and quality, since OMVbiof-vaccine induced antibodies with higher avidity. Moreover, when OMV were administered at suboptimal quantity for protection, OMVbiof-vaccine exhibited a significantly adequate and higher protective capacity against PRN(+) or PRN(-) than OMVplank-vaccine. Our findings indicate that the vaccine based on <jats:italic>B. pertussis<\/jats:italic> biofilm-derived OMV induces high protection also against pertactin-deficient strains, with a robust immune response.<\/jats:p>","DOI":"10.3389\/fimmu.2021.730434","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T04:38:01Z","timestamp":1631680681000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture"],"prefix":"10.3389","volume":"12","author":[{"given":"Francisco","family":"Carriquiriborde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Martin Aispuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Ambrosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bottero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Emilia","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Castuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Rudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An\u00edbal","family":"Lodeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela F.","family":"Hozbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000795","article-title":"Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013","volume":"34","author":"Tan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"B2","article-title":"Pertussis. A Reemerging and an Underreported Infectious Disease","volume":"35","author":"Syed","year":"2014","journal-title":"Saudi Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/MOP.0000000000000139","article-title":"Pertussis: Still a Cause of Death, Seven Decades Into Vaccination","volume":"26","author":"Jakinovich","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2015.2309","article-title":"The Pertussis Enigma: Reconciling Epidemiology, Immunology and Evolution","volume":"283","author":"Domenech de Cell\u00e8s","year":"2016","journal-title":"Proc Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000676","article-title":"Overcoming Waning Immunity in Pertussis Vaccines: Workshop of the National Institute of Allergy and Infectious Diseases","volume":"205","author":"Damron","year":"2020","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.069","article-title":"Clinical Repercussions in Pertussis Infants Post-Tdpa Vaccination of Pregnant Woman: An Immunization Success","volume":"39","author":"de Miranda Lopes","year":"2021","journal-title":"Vaccine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.15167\/2421-4248\/jpmh2020.61.1.1155","article-title":"Pertussis Immunization in Healthcare Workers Working in Pediatric Settings: Knowledge, Attitudes and Practices (KAP) of Occupational Physicians. Preliminary Results From a Web-Based Survey (2017)","volume":"61","author":"Ricc\u00f2","year":"2020","journal-title":"J Prev Med Hygiene"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2016.10.029","article-title":"Pertussis: Biology, Epidemiology and Prevention","volume-title":"Vaccine (Elsevier Ltd)","author":"Saadatian-Elahi","year":"2016"},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tim.2013.11.007","article-title":"Do We Need a New Vaccine to Control the Re-Emergence of Pertussis","volume":"22","author":"Mills","year":"2016","journal-title":"Trends Microbiol"},{"key":"B10","article-title":"New Pertussis Vaccines: A Need and a Challenge","volume-title":"Advances in Experimental Medicine and Biology.","author":"Hozbor","year":"2019"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.020","article-title":"Pertussis: Where did We Go Wrong and What can We do About it","author":"Locht","year":"2016","journal-title":"J\u00a0Infect"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv067","article-title":"Roads to the Development of Improved Pertussis Vaccines Paved by Immunology","volume":"73","author":"Brummelman","year":"2015","journal-title":"Pathog Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00125","article-title":"A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella Pertussis, Including Pertactin Deficient Strains","volume":"9","author":"Zurita","year":"2019","journal-title":"Front Cell Infection Microbiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1602051","article-title":"Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice With Bordetella Pertussis","volume":"199","author":"Wilk","year":"2017","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30646-7","article-title":"PERISCOPE: Road Towards Effective Control of Pertussis","volume":"19","author":"Diavatopoulos","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2012.05299.x","article-title":"Genotypic and Phenotypic Characterization of Bordetella Pertussis Strains Used in Different Vaccine Formulations in Latin America","volume":"112","author":"Bottero","year":"2012","journal-title":"J Appl Microbiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ng1227","article-title":"Comparative Analysis of the Genome Sequences of Bordetella Pertussis, Bordetella Parapertussis and Bordetella Bronchiseptica","volume":"35","author":"Parkhill","year":"2003","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02484-07","article-title":"Is the Sequenced Bordetella Pertussis Strain Tohama I Representative of the Species","volume":"46","author":"Caro","year":"2008","journal-title":"J Clin Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1276832","article-title":"Outer Membrane Vesicles: An Attractive Candidate for Pertussis Vaccines","volume":"16","author":"Hozbor","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.07.004","article-title":"Outer Membrane Vesicles as Acellular Vaccine Against Pertussis","volume":"26","author":"Roberts","year":"2008","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01879","article-title":"Canonical and Non-Canonical Inflammasome Activation by Outer Membrane Vesicles Derived From Bordetella Pertussis","volume":"11","author":"Elizagaray","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.12.048","article-title":"Acellular Pertussis Vaccine Based on Outer Membrane Vesicles Capable of Conferring Both Long-Lasting Immunity and Protection Against Different Strain Genotypes","volume":"32","author":"Gaillard","year":"2014","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu788","article-title":"Pertactin-Negative Bordetella Pertussis Strains: Evidence for a Possible Selective Advantage","volume":"60","author":"Martin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2334-6-53","article-title":"Analysis of Bordetella Pertussis Pertactin and Pertussis Toxin Types From Queensland, Australia, 1999-2003","volume":"6","author":"S","year":"2006","journal-title":"BMC Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3201\/eid2504.180812","article-title":"Genomic Survey of Bordetella Pertussis Diversity, United States, 2000\u20132013","volume":"25","author":"Weigand","year":"2019","journal-title":"Emerging Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000180","article-title":"Bordetella Pertussis Population Dynamics and Phylogeny in Japan After Adoption of Acellular Pertussis Vaccines","volume":"4","author":"Zomer","year":"2018","journal-title":"Microbial Genomics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3201\/eid2511.190329","article-title":"Rare Detection of Bordetella Pertussis Pertactin-Deficient Strains in Argentina","volume":"25","author":"Carriquiriborde","year":"2019","journal-title":"Emerging Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.064","article-title":"Pertactin Negative Bordetella Pertussis Demonstrates Higher Fitness Under Vaccine Selection Pressure in a Mixed Infection Model","volume":"33","author":"Safarchi","year":"2015","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.09.068","article-title":"Pertactin Deficient Bordetella Pertussis Present a Better Fitness in Mice Immunized With an Acellular Pertussis Vaccine","volume":"32","author":"Hegerle","year":"2014","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01352","article-title":"Bordetella Pertussis Isolates From Argentinean Whooping Cough Patients Display Enhanced Biofilm Formation Capacity Compared to Tohama I Reference Strain","volume":"6","author":"Arnal","year":"2015","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00373-17","article-title":"Hyperbiofilm Formation by Bordetella Pertussis Strains Correlates With Enhanced Virulence Traits","volume":"85","author":"Cattelan","year":"2017","journal-title":"Infection Immun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1038\/emi.2014.58","article-title":"The Vaccine Potential of Bordetella Pertussis Biofilm-Derived Membrane Proteins","volume":"3","author":"de Gouw","year":"2014","journal-title":"Emerging Microbes infections"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/08927014.2016.1232715","article-title":"Biofilm Forming Potential and Antimicrobial Susceptibility of Newly Emerged Western Australian Bordetella Pertussis Clinical Isolates","volume":"32","author":"Dorji","year":"2016","journal-title":"Biofouling"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2019.01.006","article-title":"Immunogenicity and Protective Potential of Bordetella Pertussis Biofilm and Its Associated Antigens in a Murine Model","volume":"337","author":"Dorji","year":"2019","journal-title":"Cell Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00177-07","article-title":"Pulsed-Field Gel Electrophoresis, Pertactin, Pertussis Toxin S1 Subunit Polymorphisms, and Surfaceome Analysis of Vaccine and Clinical Bordetella Pertussis Strains","volume":"14","author":"Bottero","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00717-13","article-title":"Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella Pertussis in the United States","volume":"21","author":"Pawloski","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.26.12.2558-2560.1988","article-title":"Use of Supplemented Stainer-Scholte Broth for the Isolation of Bordetella Pertussis From Clinical Material","volume":"26","author":"Von Koenig","year":"1988","journal-title":"J Clin Microbiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-63-2-211","article-title":"A Simple Chemically Defined Medium for the Production of Phase I Bordetella Pertussis","volume":"63","author":"Stainer","year":"1970","journal-title":"J Gen Microbiol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3791\/2437","article-title":"Microtiter Dish Biofilm Formation Assay","volume":"47","author":"O\u2019Toole","year":"2010","journal-title":"J Visualized Experiments"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/PL00006801","article-title":"Release of Outer Membrane Vesicles From Bordetella Pertussis","volume":"38","author":"Hozbor","year":"1999","journal-title":"Curr Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot102269","article-title":"Bradford Assay for Determining Protein Concentration","volume":"2020","author":"Kielkopf","year":"2020","journal-title":"Cold Spring Harbor Protoc"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.068","article-title":"Outer Membrane Vesicles Obtained From Bordetella Pertussis Tohama Expressing the Lipid a Deacylase PagL as a Novel Acellular Vaccine Candidate","volume":"29","author":"Asensio","year":"2011","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.9b00275","article-title":"Proteomic Analysis of Rhizobium Favelukesii LPU83 in Response to Acid Stress","volume":"18","author":"Nilsson","year":"2019","journal-title":"J Proteome Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.04.079","article-title":"Characterization of the Immune Response Induced by Pertussis OMVs-Based Vaccine","volume":"34","author":"Bottero","year":"2016","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01074-14","article-title":"Global Population Structure and Evolution of Bordetella Pertussis and Their Relationship With Vaccination","volume":"5","author":"Bart","year":"2014","journal-title":"mBio"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1002\/pmic.200800218","article-title":"Proteome Approaches Combined With Fourier Transform Infrared Spectroscopy Revealed a Distinctive Biofilm Physiology in Bordetella Pertussis","volume":"8","author":"Serra","year":"2008","journal-title":"Proteomics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90061-8","article-title":"Development of a Pertussis Component Vaccine In Japan","volume":"323","author":"Sato","year":"1984","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit560","article-title":"Immune Responses to Pertussis Vaccines and Disease","volume":"209","author":"Edwards","year":"2014","journal-title":"J Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00270-13","article-title":"Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed Versus Whole-Cell Vaccine-Primed Children 2 Years After Preschool Acellular Booster Vaccination","volume":"20","author":"Schure","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msq245","article-title":"Insight Into Evolution of Bordetella Pertussis From Comparative Genomic Analysis: Evidence of Vaccine-Driven Selection","volume":"28","author":"Octavia","year":"2011","journal-title":"Mol Biol Evol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001804","article-title":"Resurgence of Pertussis and Emergence of the Ptx P3 Toxin Promoter Allele in South Italy","volume":"37","author":"Loconsole","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-5728(02)00468-X","article-title":"IL-1\u03b2-Dependent Neurological Effects of the Whole Cell Pertussis Vaccine: A Role for IL-1-Associated Signalling Components in Vaccine Reactogenicity","volume":"136","author":"Armstrong","year":"2003","journal-title":"J Neuroimmunology"},{"key":"B53","first-page":"19","article-title":"Molecular Epidemiology of Bordetella Pertussis","volume-title":"Advances in Experimental Medicine and Biology.","author":"Barkoff","year":"2019"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.026","article-title":"Differences of Circulating Bordetella Pertussis Population in Argentina From the Strain Used in Vaccine Production","volume":"24","author":"Fingermann","year":"2006","journal-title":"Vaccine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29253","article-title":"Development of Improved Pertussis Vaccine","volume":"10","author":"Rumbo","year":"2014","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105011","article-title":"Proteomics-Identified Bvg-Activated Autotransporters Protect Against Bordetella Pertussis in a Mouse Model","volume":"9","author":"de Gouw","year":"2014","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JPROTEOME.5B00258","article-title":"Immunoproteomic Profiling of Bordetella Pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity","volume":"14","author":"RH","year":"2015","journal-title":"J Proteome Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1128\/IAI.67.3.1424-1431.1999","article-title":"Characterization of Human Bactericidal Antibodies to Bordetella Pertussis","volume":"67","author":"Weiss","year":"1999","journal-title":"Infection Immun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.730434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T04:38:09Z","timestamp":1631680689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.730434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2021.730434"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.730434","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"article-number":"730434"}}